TILs included CD4+, CD8+, and FOXP3+ T cells, and all subsets were significantly reduced in the cancerous tissues compared to the cancer stromal tissues (Figure 2A, Figure 2—figure supplement 1C). The gene discussed is CD4; the disease is cancer.